The healthcare sector generates 30% of all data worldwide. Yet 97% of the knowledge within it remains untapped, leaving critical health insights hidden.
Floy® unlocks the full potential of every radiological image. This is how we transform unused data into timely therapy.
Floy® opportunistically assesses bone density in routine MRI and CT images of the spine in order to identify high-risk patients and thus enables timely measures to prevent bone fractures.
Floy® opportunistically assesses coronary calcifications in routine chest CT scans, which may indicate the presence of coronary artery disease.
Learn more
Floy® opportunistically assesses vascular calcifications in mammography, which may indicate an increased risk for cardiovascular diseases such as heart attack or stroke.
Learn more
Floy® opportunistically assesses potentially pathological brain changes that may indicate impaired blood flow or small vessel damage, which are associated with stroke and dementia.
Floy® opportunistically detects aneurysms in routine T2-weighted brain MRIs. If left untreated, an intracranial aneurysm carries a high risk of life-threatening brain hemorrhage.
Learn more
Floy® opportunistically quantifies liver fat in MRI and CT scans to enable early assessment of metabolic health risk factors.
